Compliance to the prescribed dose and overall treatment time in five randomized clinical trials of altered fractionation in radiotherapy for head-and-neck carcinomas
- 1 March 2003
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 55 (3) , 568-575
- https://doi.org/10.1016/s0360-3016(02)03790-2
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Critical Review of Interventions to Increase Compliance with Medication-Taking, Obtaining Medication Refills, and Appointment-Keeping in the Treatment of Cardiovascular DiseasePreventive Medicine, 1999
- Outstanding issues in radiation dose-fractionation studiesInternational Journal of Radiation Biology, 1998
- A modelled comparison of the effects of using different ways to compensate for missed treatment days in radiotherapyClinical Oncology, 1996
- Radiotherapy for T2 and T3 carcinoma of the bladder: the influence of overall treatment timeRadiotherapy and Oncology, 1995
- The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effectsRadiotherapy and Oncology, 1995
- Actual versus ideal treatment time in radiotherapy for head and neck cancer: Catching up with the gapsInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Planned and unplanned gaps in radiotherapy: the importance of gap position and gap durationRadiotherapy and Oncology, 1994
- The effect of overall treatment time on the outcome of definitive radiotherapy for localized prostate carcinoma: The radiation therapy oncology group 75-06 and 77-06 experienceInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Clinical radiobiology of squamous cell carcinoma of the oropharynxInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Evaluation of unplanned interruptions in radiotherapy treatment schedulesInternational Journal of Radiation Oncology*Biology*Physics, 1988